Breast Cancer

Latest News


The Food and Drug Administration (FDA) has granted an approval to Trazimera (PF-05280014; trastuzumab-qyyp), a Herceptin (trastuzumab) biosimilar, to treat patients with HER2-overexpressing breast cancer as well as HER2-overexpressing metastatic gastric or gastroesophageal junction adenocarcinoma.

Can at-home DNA testing kits accurately help us discover important health information? What do we do with the information once we receive it? In this post, learn more about the pros and cons.

The Food and Drug Administration has granted an accelerated approval to the frontline combination of Tecentriq (atezolizumab) plus Abraxane (nab-paclitaxel) for patients with unresectable locally advanced or metastatic PD-L1–positive triple-negative breast cancer (TNBC).

What started as a hangnail turned into one of the most difficult late effects of breast cancer. This survivor found swimming to be a viable treatment for her lymphedema.

Survivors with children face some of the biggest challenges when it comes to visualizing the future. After my breast cancer diagnosis in 1986, it was my daughter's future, rather than my own, for which I bargained.